These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 7026399
1. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines]. Sarateanu DE, Ehrengut W. Fortschr Med; 1981 Sep 10; 99(34):1348-52. PubMed ID: 7026399 [No Abstract] [Full Text] [Related]
2. [Preventive influenza vaccination--possibilities and limits in the prevention of influenza-virus infections]. Wesselius-de Casparis A. Med Monatsschr; 1973 Oct 10; 27(10):447-9. PubMed ID: 4777787 [No Abstract] [Full Text] [Related]
3. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults. Levie K, Leroux-Roels I, Hoppenbrouwers K, Kervyn AD, Vandermeulen C, Forgus S, Leroux-Roels G, Pichon S, Kusters I. J Infect Dis; 2008 Sep 01; 198(5):642-9. PubMed ID: 18576945 [Abstract] [Full Text] [Related]
4. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol; 2004 Apr 01; 113(4):717-24. PubMed ID: 15100679 [Abstract] [Full Text] [Related]
5. No effect of a traditional Chinese medicine, Hochu-ekki-to, on antibody titer after influenza vaccination in man: a randomized, placebo-controlled, double-blind trial. Hamazaki K, Sawazaki S, Itomura M, Huan M, Shibahara N, Kawakita T, Kobayashi S, Hamazaki T. Phytomedicine; 2007 Jan 01; 14(1):11-4. PubMed ID: 16644196 [Abstract] [Full Text] [Related]
9. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans. Závadová H. Acta Virol; 1973 Jul 01; 17(4):287-92. PubMed ID: 4148207 [No Abstract] [Full Text] [Related]
10. [Comparative study of immunogenicity and safety of domestic influenza vaccines]. Yao J, Li Q, Xu Q, Feng CF, Lu YM, Xu BQ, Lu Y. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 01; 25(8):735. PubMed ID: 15555412 [No Abstract] [Full Text] [Related]
11. [Antigenicity of various influenza vaccines in man]. Kuwert E, Höhner PG, Bertrams J, Schriever O. Dtsch Med Wochenschr; 1971 May 28; 96(22):938-45. PubMed ID: 4325348 [No Abstract] [Full Text] [Related]
12. An electroaerosol device for group vaccination against influenza. Grinshpun L, Priimägi L, Subi K, Reinet J, Visnapuu L. Z Erkr Atmungsorgane; 1978 Mar 28; 150(3):237-8. PubMed ID: 695738 [Abstract] [Full Text] [Related]
14. [Comparative studies in influenza vaccines]. Kunz C, Wiedermann G, Dostal V. Wien Med Wochenschr; 1975 Oct 03; 125(40):581-2. PubMed ID: 1226778 [No Abstract] [Full Text] [Related]
19. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Vaccine; 2006 Nov 10; 24(44-46):6620-3. PubMed ID: 16870313 [Abstract] [Full Text] [Related]
20. [Balanced and normative view on preventive influenza vaccination in the GFR (German Federal Republic) on an experimental basis]. Kuwert E. Med Monatsschr; 1973 Oct 10; 27(10):438-47. PubMed ID: 4777786 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]